<?xml version='1.0' encoding='UTF-8'?>
<PolymerNanocomposite><PDB_ID>4B6L</PDB_ID><DATA_SOURCE><Citation><Publication>To be Published</Publication><Title>Discovery of Oral Polo-Like Kinase (Plk) Inhibitors with Enhanced Selectivity Profile Using Residue Targeted Drug Design</Title><Author>Brown, K.</Author><Author>Charrier, J.D.</Author><Author>Durrant, S.</Author><Author>Griffiths, M.</Author><Author>Hudson, C.</Author><Author>Kay, D.</Author><Author>Knegtel, R.</Author><Author>Odonnell, M.</Author><Author>Pierard, F.</Author><Author>Twin, H.</Author><Author>Weber, P.</Author><Author>Young, S.</Author><DateOfCitation>2013-08-21</DateOfCitation></Citation></DATA_SOURCE><MATERIALS><Matrix><MatrixComponent><ChemicalName>Serine/threonine-protein kinase PLK3</ChemicalName><MacroMoleculeClass>TRANSFERASE</MacroMoleculeClass><MacroMoleculeType>Protein</MacroMoleculeType><ManufacturerOrSourceName>Homo sapiens</ManufacturerOrSourceName><MolecularWeight><value>32790.87</value></MolecularWeight></MatrixComponent></Matrix></MATERIALS><CHARACTERIZATION><XRay_Diffraction_and_Scattering><Equipment>SRS BEAMLINE PX9.5 ADSC QUANTUM 4</Equipment><Description>Data collection temperature: 100 K, Resolution: 1.9</Description></XRay_Diffraction_and_Scattering></CHARACTERIZATION><PROPERTIES><Biological><Sequence>LITDPRSGRTYLKGRLLGKGGFARCYEATDTETGSAYAVKVIPQSRVAKPHQREKILNEIELHRDLQHRHIVRFSHHFEDADNIYIFLELCSRKSLAHIWKARHTLLEPEVRYYLRQILSGLKYLHQRGILHRDLKLGNFFITENMELKVGDFGLAARLEPPEQRKKTICGTPNYVAPEVLLRQGHGPEADVWSLGCVMYTLLCGSPPFETADLKETYRCIKQVHYTLPASLSLPARQLLAAILRASPRDRPSIDQILRHDFFTKGYTPDRLPISSCVTVP</Sequence><SpaceGroup>C 1 2 1</SpaceGroup></Biological></PROPERTIES></PolymerNanocomposite>